NSE · MEDANTA
Global Health Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹1,208 Cr with net profit ₹181 Cr — a 15% net margin, versus 12.73% the period before.
Shareholding
As of 2026-09-30
- Promoter33%
- Public40.09%
- FII9.91%
- DII17.01%
1,35,371 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.62× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #7 of 87 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,21,441 Cr | 53.63 | 11.45 | 21.14% | 8.12% |
| Max Healthcare Institute Ltd. | ₹90,909 Cr | 64.02 | 8.02 | 12.18% | 15.1% |
| Manipal Health Enterpri Limited | ₹85,065 Cr | 90.7 | 5.18 | 10.59% | 7.81% |
| Aster DM Quality Care Ltd. | ₹62,142 Cr | 160.2 | 14.77 | 8.48% | 6.54% |
| Fortis Healthcare Ltd. | ₹57,898 Cr | 54.27 | 5.53 | 9.91% | 10.48% |
| Narayana Hrudayalaya Ltd. | ₹38,890 Cr | 42.98 | 7.77 | 17.17% | 8.36% |
| Global Health Limited(this company) | ₹37,309 Cr | 57.62 | 8.63 | 14.3% | 12.24% |
| Dr. Lal Path Labs Ltd. | ₹33,066 Cr | 54.59 | 12.03 | 21.32% | 19.29% |
| Krishna Institute of Medical Sciences Ltd. | ₹30,366 Cr | 149.38 | 7.72 | 5.4% | 4.62% |
| Dr. Agarwal's Health Care Limited | ₹16,371 Cr | 111.04 | 7.32 | 8.04% | 7.61% |
AI analysis
AI-generated · google/gemini-2.5-flashGlobal Health Limited, operating under the symbol MEDANTA, has a market capitalization of Rs 35798 Cr. The company reported a revenue of Rs 4410.27 Cr with a profit margin of 12.62%. Its earnings per share (EPS) stands at Rs 20.73, and the stock is trading at a PE ratio of 248.4.
Positives
- +The company's revenue grew by 12.7%, indicating business expansion.
- +The debt-to-equity ratio is 0.24, suggesting a manageable debt level.
- +Promoter holding of 32.9992% is not pledged.
Negatives
- −The company's PE ratio is 248.4, which is high.
- −The promoter holding decreased from 33.0739% in June 2023 to 32.9992% in June 2026.
- −No quarterly results have been disclosed since March 2026.
Financial Performance
Global Health Limited recorded a revenue of Rs 4410.27 Cr, demonstrating a revenue growth of 12.7%. The net profit for the annual period ending March 2026 was Rs 556.46 Cr. For the quarter ending March 2026, the company's revenue was Rs 1159.05 Cr, with a net profit of Rs 143.99 Cr.
Profitability & Returns
The company’s profit margin is 12.62%. Return on equity (ROE) is 14.05%, and return on capital employed (ROCE) is 15.26%. The basic earnings per share (EPS) is Rs 20.73.
Balance Sheet
Global Health Limited has a book value per share of Rs 147.34. The debt-to-equity ratio is 0.24, indicating a modest level of debt relative to equity. The company does not currently offer a dividend, with a dividend yield of 0%.
Ownership & Pledges
Public shareholding stands at 40.6496%. There are no promoter shares pledged.
Regulatory & Surveillance
The company is not currently under any regulatory surveillance actions.
Data as of — price: 2026-11-07 · financials: Sep 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.